RapidPulse, a Miami FL-based medical device company developing an aspiration system to treat ischemic stroke, raised $15M in Series A funding.
The round was led by Santé Ventures with participation from Epidarex Capital, Hatteras Venture Partners, Broadview Ventures, and Syntheon.
The company plans to use the funds to advance its system through expanded clinical evaluation and build out its platform of proprietary catheters.
Led by Sean McBrayer, CEO, RapidPulse is developing a novel aspiration system to treat ischemic stroke. The RapidPulse™ Cyclic Aspiration System includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain.
RapidPulse is a spinout of Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry.
FinSMEs
29/06/2021